Teva Hurt As Merck Cuts Prices

Shares of generic drug maker Teva Pharmaceutical Industries Ltd. (TEVA) plunged $3.40 to close at $32.27 after Merck & Co. (MRK) announced price cuts to its cholesterol medication Zocor. Merck stock edged up 35 cents to close at $35.27.